GBNH - Mental Health Treatment: Compass Pathways And Greenbrook TMS Join Forces For Psilocybin Therapy Research | Benzinga
Biotechnology company Compass Pathways plc (NASDAQ: CMPS) and Greenbrook TMS Inc (NASDAQ: GBNH) have entered into a three-year research collaboration agreement to explore delivery models for investigational COMP360 psilocybin treatment.
The parties will research and investigate models for the delivery of scalable, commercial ...